- Home
- SRPT vs VOR Comparison
SRPT vs VOR Comparison
Compare SRPT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- VOR
- Stock Information
- Founded
- SRPT 1980
- VOR 2015
- Country
- SRPT United States
- VOR United States
- Employees
- SRPT 1372
- VOR N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- SRPT Health Care
- VOR Health Care
- Exchange
- SRPT Nasdaq
- VOR Nasdaq
- Market Cap
- SRPT 1.7B
- VOR 22.1M
- IPO Year
- SRPT 1997
- VOR 2021
- Fundamental
- Price
- SRPT $18.19
- VOR $1.84
- Analyst Decision
- SRPT Buy
- VOR Buy
- Analyst Count
- SRPT 25
- VOR 7
- Target Price
- SRPT $64.00
- VOR $3.77
- AVG Volume (30 Days)
- SRPT 7.9M
- VOR 40.7M
- Earning Date
- SRPT 08-06-2025
- VOR 08-07-2025
- Dividend Yield
- SRPT N/A
- VOR N/A
- EPS Growth
- SRPT N/A
- VOR N/A
- EPS
- SRPT N/A
- VOR N/A
- Revenue
- SRPT $2,233,371,000.00
- VOR N/A
- Revenue This Year
- SRPT $26.87
- VOR N/A
- Revenue Next Year
- SRPT $3.15
- VOR N/A
- P/E Ratio
- SRPT N/A
- VOR N/A
- Revenue Growth
- SRPT 59.15
- VOR N/A
- 52 Week Low
- SRPT $16.88
- VOR $0.13
- 52 Week High
- SRPT $155.95
- VOR $2.04
- Technical
- Relative Strength Index (RSI)
- SRPT 23.09
- VOR 86.80
- Support Level
- SRPT $16.88
- VOR $0.29
- Resistance Level
- SRPT $18.62
- VOR $2.04
- Average True Range (ATR)
- SRPT 1.40
- VOR 0.27
- MACD
- SRPT 0.09
- VOR 0.17
- Stochastic Oscillator
- SRPT 6.41
- VOR 93.01
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.